{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:34:06Z","timestamp":1793450046078,"version":"4.5.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jaad.2026.10.052","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:05:53Z","timestamp":1792739153000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A clinician\u2019s perspective: January 2027\u2014When suspecting rapidly progressive interstitial lung disease in MDA5 dermatomyositis, consider taking the serum amyloid A train"],"prefix":"10.1016","author":[{"given":"Warren R.","family":"Heymann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaad.2026.10.052_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41584-023-01054-9","article-title":"Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress","volume":"20","author":"Lu","year":"2024","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.jaad.2026.10.052_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12931-025-03347-x","article-title":"Spontaneous pneumomediastinum and\/or pneumothorax in anti-MDA5 dermatomyositis: a refined staging system","volume":"26","author":"Jin","year":"2025","journal-title":"Respir Res"},{"key":"10.1016\/j.jaad.2026.10.052_bib3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/978-3-030-41769-7_17","article-title":"Serum Amyloid A (SAA) Proteins","volume":"94","author":"Sack","year":"2020","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.jaad.2026.10.052_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2026.08.087","article-title":"Elevated serum amyloid A levels are associated with rapidly progressive interstitial lung disease in dermatomyositis: a retrospective cohort study","author":"Shih","year":"2026","journal-title":"J Am Acad Dermatol"},{"issue":"suppl 9","key":"10.1016\/j.jaad.2026.10.052_bib5","article-title":"Brepocitinib demonstrates consistent clinical responses along with reduced oral corticosteroid use in dermatomyositis patients with interstitial lung disease: results from the phase 3 VALOR trial [abstract]","volume":"78","author":"Menon","year":"2026","journal-title":"Arthritis Rheumatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226038065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226038065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:15:46Z","timestamp":1793448946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226038065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":5,"alternative-id":["S0190962226038065"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.10.052","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A clinician\u2019s perspective: January 2027\u2014When suspecting rapidly progressive interstitial lung disease in MDA5 dermatomyositis, consider taking the serum amyloid A train","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.10.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}